1. Orphan drugs: FDA could improve designation review consistency; rare disease drug development challenges continue : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, November 2018 Subject(s): Drug ApprovalOrphan Drug ProductionUnited StatesUnited States. Food and Drug Administration.
